Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134747) titled 'Study of the blood-interstitial fluid glucose gradient for early warning and dynamic classification of skin failure in patients with sepsis' on Oct. 20.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Drum Tower Hospital
Condition:
Sepsis Acute skin failure
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2027-01-01
Target Sample Size: Exposure group:500;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=341726
Disclaimer: Curated by HT Syndication....